Clinical Trial Update: Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Opioid Use Disorders | Phase 3 | Status: COMPLETED | Results posted: 2020-01-22